Actualités

Désolé, cet article est seulement disponible en Anglais Américain.

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Call for Abstracts and Society Prize Submissions for the Anti-NMDA Receptor Encephalitis Foundation Prize 2022. From www.antinmdafoundation.org - January 16, 5:45 PM Once again, the Canadian Neurological Sciences Federation (CNSF) is calling for submissions of Abstracts and Society prize submissions…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy | Neurology Neuroimmunology & Neuroinflammation From nn.neurology.org - January 6, 6:26 PM Except for the high frequency of patients in the age ≥45 years, our cohort showed…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

BREAKING NEWS! First Clinical Trial for Anti-NMDA Receptor Encephalitis From mailchi.mp - December 3, 10:26 PM In the spring of 2020, the Foundation expressed its strong support for the first-ever Clinical Trial for a promising new drug to treat anti-NMDA…

The Voices of Anti-NMDA – Jayden Liuzza

It’s time that we are seen and heard! The Foundation is honoured to hear the voice of our Ambassador, Jayden Liuzza. We believe that this is a more effective and powerful way for those of us affected by anti-NMDA to…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Neural Antibody Testing for Autoimmune Encephalitis: A Canadian Single-Centre Experience | Canadian Journal of Neurological Sciences From www.cambridge.org - November 16, 3:43 PM Neural Antibody Testing for Autoimmune Encephalitis: A Canadian Single-Centre Experience - Volume 48 Issue 6   The…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis | Neurology Neuroimmunology & Neuroinflammation From nn.neurology.org - Today, 10:33 AM Immunotherapeutic strategies for GAD65-AE remain highly controversial.27 Most patients are considered to require immunotherapy, and early immunotherapy has been…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Long‐term cognitive outcome in anti‐NMDA receptor encephalitis - Heine - - Annals of Neurology From onlinelibrary.wiley.com - October 6, 8:42 AM Objective Cognitive dysfunction is a core symptom of NMDAR encephalitis, but detailed studies on prevalence, characteristics of cognitive deficits,…

The Anti-NMDA Receptor Encephalitis Foundation Newsletter

Long‐term cognitive outcome in anti‐NMDA receptor encephalitis - Heine - - Annals of Neurology From onlinelibrary.wiley.com - October 6, 8:42 AM Objective Cognitive dysfunction is a core symptom of NMDAR encephalitis, but detailed studies on prevalence, characteristics of cognitive deficits,…